Pipeline Preview

News
Article

Methylphenidate transdermal patch (Daytrana, Shire/Noven) to treat attention-deficit/hyperactivity disorder (ADHD)

Recommendations for approval

Approvable designations

Fast-track designation

Priority review

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.